Essilor is pursuing its acquisition policy
Essilor International is shunned by investors on Friday in the Paris Bourse. Shortly after the opening of markets, the value decreased by 0.68% to 48.70 euros while the CAC 40 advances from 0.15% to 3824.89 points. The world leader in ophthalmic lenses announced in a statement Friday it would invest 130 million dollars (92.3 million) to buy 50% of the Israeli group Shamir Optical. Specializing in innovative technologies applied to corrective lenses, the Israeli group reported 2009 sales of 142 million dollars (100 million euros), especially in Europe and the United States.
Cedric Rossi, an analyst at Aurel BCG, there is no need to worry. "While the transaction is not very significant across the group. It represents an increase of 50 million euros in turnover Essilor, or 1.5% increase.He added: "But the stagnation of their value over the fact that the sector has not experienced significant rebound like the cosmetic."
"The concern is that Essilor does not acquire"
In this context, the group sticks to the strategy it takes since the 1990s, namely accumulate acquisitions to increase its market share. In the first quarter, inter alia, it acquired the Canadian and American Signet FGX International, which unlike most of the companies acquired by Essilor, specializes in glasses without prescription guaranteed approval cash advance loans. The acquisition of the Israeli Shalit Optical one of them. "This partnership will allow us to grow the global market perspective, by offering new products and value added services," said Hubert Sagnières, CEO of Essilor, quoted in the statement."This operation should not worry investors, says Cedric Rossi. Essilor us used every year in many acquisitions. The concern would rather he did not do. "
The transaction will take the form of a merger with a 100% subsidiary of Essilor, prior to a delisting of the Tel Aviv Stock Exchange and Nasdaq. Shareholders other than the community of Kibbutz Shamir will receive a cash payment of an unspecified amount in exchange for their shares. "It is anticipated that the transaction is accretive," that is to say, it increases the earnings per share of Essilor in 2011, excluding the impact of the acquisition price, the company said.
Essilor will remain between 47 and 50 euros
The transaction should be finalized by mid-2011. The analyst Aurel BCG sees no immediate impact on the value that will, according to him, continue to stagnate between 47 and 50 euros."And, as organic growth Essilor will not increase," Rossi said Cedric. However, at Aurel BCG, it is anticipated organic growth of between 3.5% and 4% or below current levels (around 5%).
